Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P López-Saura

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Revista De Neurologia|April 1, 2000
[Alpha interferon and Alzheimer's disease]J A Cabrera-Gómez, P López-Saura
Revista De Neurologia|February 1, 2000
[Recent advances in the treatment the nervous system disorders with interferon-alpha]J A Cabrera-Gómez, P López-Saura
Revista De Neurologia|July 3, 1999
[Alpha interferon in the treatment of multiple sclerosis. Update and experience in Cuba]J A Cabrera-Gómez, P López-Saura
Acta Cientifica Venezolana|January 1, 1993
[Expression of interferon alpha receptors in cell lines from human tumors. Relationship with the antiproliferative effect]S E Perea, H Gerónimo, P López Saura
Revue Roumaine De Virologie (Bucharest, Romania : 1990)|July 1, 1990
Antiviral effect of interferon: the interferon in viral hepatitisC Castañeda Guillot, A Sotto Escobar, P López Saura
Biotherapy (Dordrecht, Netherlands)|January 1, 1994
Use of recombinant interferon-alpha in human immunodeficiency virus (HIV)-infected individualsJ Rivero, M Limonta, A Aguilera, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1997
Long-term treatment with recombinant interferon alpha-2b prolongs survival of asymptomatic HIV-infected individualsJ Rivero, M Fraga, I Cancio, et al.
Biotherapy (Dordrecht, Netherlands)|June 9, 1998
Use of recombinant interferon gamma in pediatric patients with advanced juvenile chronic arthritisC Coto, G Varela, V Hernández, et al.
Biotherapy (Dordrecht, Netherlands)|June 9, 1998
High levels of soluble IFN gamma receptor alpha chain in the plasma of rheumatoid arthritis patientsI Bello, A Perez, A M Torres, et al.
Journal of Interferon Research|October 1, 1993
Partial phenotypic reversion of HeLa cells by long-term interferon-alpha treatmentO López Ocejo, S E Perea, A Reyes, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Revista De Neurologia|April 1, 2000
[Alpha interferon and Alzheimer's disease]J A Cabrera-Gómez, P López-Saura
Revista De Neurologia|February 1, 2000
[Recent advances in the treatment the nervous system disorders with interferon-alpha]J A Cabrera-Gómez, P López-Saura
Revista De Neurologia|July 3, 1999
[Alpha interferon in the treatment of multiple sclerosis. Update and experience in Cuba]J A Cabrera-Gómez, P López-Saura
Acta Cientifica Venezolana|January 1, 1993
[Expression of interferon alpha receptors in cell lines from human tumors. Relationship with the antiproliferative effect]S E Perea, H Gerónimo, P López Saura
Revue Roumaine De Virologie (Bucharest, Romania : 1990)|July 1, 1990
Antiviral effect of interferon: the interferon in viral hepatitisC Castañeda Guillot, A Sotto Escobar, P López Saura
Biotherapy (Dordrecht, Netherlands)|January 1, 1994
Use of recombinant interferon-alpha in human immunodeficiency virus (HIV)-infected individualsJ Rivero, M Limonta, A Aguilera, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1997
Long-term treatment with recombinant interferon alpha-2b prolongs survival of asymptomatic HIV-infected individualsJ Rivero, M Fraga, I Cancio, et al.
Biotherapy (Dordrecht, Netherlands)|June 9, 1998
Use of recombinant interferon gamma in pediatric patients with advanced juvenile chronic arthritisC Coto, G Varela, V Hernández, et al.
Biotherapy (Dordrecht, Netherlands)|June 9, 1998
High levels of soluble IFN gamma receptor alpha chain in the plasma of rheumatoid arthritis patientsI Bello, A Perez, A M Torres, et al.
Journal of Interferon Research|October 1, 1993
Partial phenotypic reversion of HeLa cells by long-term interferon-alpha treatmentO López Ocejo, S E Perea, A Reyes, et al.
Pageof 2